Brief: Redwood Pharma April-June Operating Loss Widens To SEK 4 Mln

Redwood Pharma AB

07/08/2023 07:37

Aug 7 (Reuters) - Redwood Pharma AB  REDWPH.ST :
    * APRIL-JUNE OPERATING LOSS SEK 4.0 MILLION VERSUS LOSS SEK
3.1
MILLION YEAR AGO
    * CO IS CURRENTLY EVALUATING THE POSSIBILITY OF DIVESTING OR
OUT-LICENSE THE RP101 CLINICAL PROGRAM TO A LARGER INDUSTRY
PLAYER
    * SUCH AGREEMENT WOULD GENERATE BUSINESS REVENUE FOR REDWOOD
PHARMA IN THE FORM OF PAYMENTS UPON ACHIEVED MILESTONES AND
FUTURE ROYALTIES

Source text for Eikon:  ID:nWkr48SvvM 
Further company coverage:  REDWPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))